Researchers New Brigham have found in a new study that MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer. A new meta-analysis by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that doctors and patients […]
A comprehensive study highlighted the significant disparities in the health outcomes of diabetes patients across the United States by focusing the impact of living in rural areas versus urban centers. The key findings of the study were published in the Diabetes Care journal. This study utilized data from the OptumLabs Data Warehouse which included a […]
USA: Findings from a 5-year follow-up of the EXCEL trial revealed that surgery has the upper hand over angioplasty for revascularization for left main coronary disease concerning hospital readmission rates. The study was published online in the Journal of the American College of Cardiology. In the EXCEL trial, readmission during 5-year follow-up after revascularization for […]
The global population of patients with diabetic wounds is expected to rise to between 9.1 million to 26.1 million by 2030. Diabetic wounds severely impact patients’ quality of life, both physically and mentally while also imposing a substantial economic burden on healthcare systems. Current treatment methods for diabetic wounds include surgical debridement, negative pressure wound […]
A recent study published in the recent edition of Drug and Alcohol Dependence journal highlighted that d-limonene, a terpenoid found in cannabis, can reduce the anxiety-inducing effects of delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of the plant. This finding challenges the existing understanding of the effects of cannabis and supports the entourage effect theory, which proposes […]
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Novo Nordisk’s Protocol Amendment proposal for the antidiabetic drug Semaglutide study. This came after the drug maker Novo Nordisk presented protocol amendment version 5.0 dated 07 September 2023 protocol No: NN9924-4437. This is a […]
New Delhi: Pharmaceutical major Cipla has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to import and market Human insulin inhalation powder with inhaler [Technosphere insulin 4U/ 8U/ 12U] for the indication “to improve glycemic control in adult patients with diabetes mellitus”. However, the nod […]
Bengaluru: The Urbal II Additional District Consumer Disputes Redressal Commission, Bengaluru recently directed an Orthopaedic Surgeon to pay around Rs 4 lakh compensation to a patient for medical negligence while conducting Total Knee Replacement Surgery. After the surgery, the patient had to suffer unbearable pain and had to seek treatment at another hospital. The Consumer Court […]
Jammu & Kashmir- Through a recent notice, the Jammu & Kashmir (J&K) Board has announced admission to the B.Sc. Nursing, B.Sc. Paramedical and B.Sc. Technology Courses for 2024 session in Government and Private Colleges and Institutions of UT of J&K. The period for submission of online application form is from 30 March 2024 to 13 […]
Cambridge: AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult patients with unresectable or recurrent PIK3CA, AKT1, or PTEN-altered hormone receptor (HR)-positive, HER2-negative breast cancer following progression after treatment with endocrine therapy. The approval by the Japanese Ministry of Health, Labour, and Welfare (MHLW) was based […]